Ciprobid Injection (Ciprofloxacin) | Used for Respiratory, Urinary and Skin Infections
Ciprobid Injection is a sterile intravenous formulation of Ciprofloxacin, used to treat severe or life-threatening bacterial infections like pneumonia, complicated urinary tract infections (UTIs), abdominal infections, and skin/bone infections. It belongs to an antibiotic class where Ciprofloxacin is an active ingredient used to treat bacterial infections.
Product Overview
Ciprobid Injection is a high-potency intravenous antibacterial agent containing Ciprofloxacin, a member of the fluoroquinolone class. It is specifically designed for the treatment of severe systemic infections where oral administration is not feasible or rapid therapeutic onset is required. Ciprobid Injection is a broad-spectrum antibiotic effectively eliminates a wide range of pathogens responsible for complex respiratory, urinary, and abdominal conditions.
Product Composition
- Ciprofloxacin: A potent second-generation fluoroquinolone that provides extensive coverage against both Gram-negative and Gram-positive bacteria.
- Sterile Aqueous Base: A pH-adjusted, pyrogen-free vehicle formulated for intravenous infusion to ensure maximum bioavailability.
- Lactic Acid / Hydrochloric Acid: Used as buffering agents to stabilize the active pharmaceutical ingredient and maintain the correct osmolarity for patient safety.
Product Specification
| Attribute | Specification |
| Dosage Form | Sterile Solution for Infusion |
| Pharmacological Group | Quinolone Antibiotics |
| Mode of Delivery | Intravenous (IV) Infusion |
| Bacterial Target | Bactericidal action against aerobic and anaerobic pathogens |
| Compatibility | Compatible with 0.9% NaCl or 5% Dextrose solutions |
Mechanism of Action
- Ciprobid Injection exerts its bactericidal effect by inhibiting the essential bacterial enzymes DNA gyrase and topoisomerase IV.
- The inhibition of DNA gyrase prevents the supercoiling of DNA, which is a necessary step for bacterial DNA replication.
- By blocking topoisomerase IV, the medication interferes with the separation of replicated chromosomal DNA, effectively halting bacterial cell division.
- This dual-target mechanism ensures the rapid destruction of pathogens, even in high-density bacterial populations found in acute infections.
Key Benefits
- Ensures 100% bioavailability through direct systemic delivery, bypassing the gastrointestinal tract for faster infection control.
- Provides a wide therapeutic window against complicated Urinary Tract Infections (UTI) and hospital-acquired pneumonia.
- Highly effective for empiric therapy in cases where the causative organism has not yet been identified through cultures.
- Facilitates a smoother transition to oral therapy once the patient’s condition has stabilized, supporting sequential antibiotic treatment.
- Offers excellent tissue penetration, ensuring the medication reaches deep-seated infection sites such as bones, joints, and the prostate.
Precautions
| General Precaution | Details |
|---|---|
| For hospital use only | Ciprobid Injection should be given by a healthcare professional |
| Not for self use | Do not attempt self-injection |
| Complete full course | Stopping early may cause infection to return |
| Use with caution | May increase risk of side effects in sensitive patients |
| Avoid misuse | Overuse can lead to antibiotic resistance |
| Kidney and liver monitoring | Dose adjustment may be needed in impairment |
Medical Supervision
- Always use Ciprobid Injection under strict medical supervision
- Inform your doctor about allergies or previous antibiotic reactions
- Share your full medical history before treatment
Special Health Conditions
- Use carefully in patients with kidney or liver disease
- Caution in patients with epilepsy or neurological disorders
- May require dose adjustment in elderly patients
During Treatment Care
- Stay hydrated during therapy unless advised otherwise
- Avoid skipping doses for best results
- Report any unusual symptoms immediately
Pregnancy and Breastfeeding
- Use only if clearly prescribed by a doctor
- Not recommended unless benefits outweigh risks
Drug Safety Tips
- Avoid mixing with other antibiotics without medical advice
- Inform doctor about all ongoing medications
- Do not consume alcohol during treatment if advised against it
Usage
Dosage
The standard adult dosage typically ranges from 200 mg to 400 mg administered twice daily, depending on the severity and site of the bacterial infection.
For chronic bronchial infections or severe pneumonia, the dose is often adjusted to 400 mg every 8 to 12 hours.
Patients with renal impairment (reduced kidney function) require specific dosage adjustments based on their creatinine clearance levels to prevent toxicity.
The duration of treatment is determined by the physician, usually lasting between 7 to 14 days, though bone infections may require longer cycles.
Administration
Ciprobid Injection must be administered by slow intravenous infusion over a period of 60 minutes to minimize the risk of venous irritation.
The solution should be inspected visually for particulate matter or discoloration before the infusion begins.
It is vital to maintain adequate hydration for the patient throughout the treatment course to prevent the formation of crystals in the urine (crystalluria).
Infusion should be made into a large vein to reduce the risk of thrombophlebitis and local tissue reaction.
The medication should not be mixed with other drugs in the same infusion bag to avoid chemical physical incompatibilities.
Clinical Administration Parameters
| Parameter | Clinical Guideline |
| Infusion Rate | Not less than 60 minutes for a 400 mg dose |
| Dilution Requirement | Can be administered undiluted or added to compatible IV fluids |
| Patient Monitoring | Monitor for signs of tendon pain or hypersensitivity reactions |
| Switching to Oral | Transition to Ciprofloxacin tablets once clinical improvement is noted |
Uses
Treatment of complicated urinary tract infections (cUTI) and acute pyelonephritis where multi-drug resistance is suspected.
Management of lower respiratory tract infections, including severe pneumonia caused by Gram-negative pathogens like Pseudomonas aeruginosa.
Resolution of intra-abdominal infections, often used in combination with other agents to provide comprehensive anaerobic coverage.
Therapy for bone and joint infections (osteomyelitis) due to the drug's superior ability to achieve high tissue penetration.
Prophylaxis and treatment of inhalational anthrax following suspected or confirmed exposure to Bacillus anthracis.
Treatment of typhoid fever (enteric fever) caused by susceptible strains of Salmonella typhi.
Side Effects
Common Side Effects
- Nausea or vomiting
- Diarrhea
- Headache
- Dizziness
- Injection site pain or irritation
Less Common Side Effects
- Loss of appetite
- Abdominal discomfort
- Skin rash or itching
- Sleep disturbances
- Increased sensitivity to sunlight
Serious Side Effects
| Serious Side Effect | Details |
|---|---|
| Severe allergic reaction | May cause swelling, rash or breathing difficulty |
| Tendon damage | Pain or swelling in joints or tendons |
| Nervous system effects | Confusion, seizures or severe dizziness |
| Severe diarrhea | May indicate serious intestinal infection |
| Liver or kidney issues | Yellowing of skin or abnormal lab values |
When to Seek Medical Help
- If you develop signs of allergy such as swelling or breathing trouble
- If severe or persistent diarrhea occurs
- If joint pain or tendon discomfort develops
- If unusual mood changes or seizures appear
FAQs
Q: What is Ciprobid Injection?
A: Ciprobid Injection is a sterile intravenous formulation of Ciprofloxacin, a broad-spectrum fluoroquinolone antibiotic used to treat serious bacterial infections in hospitalized patients.
Q: What conditions does Ciprobid Injection treat?
A: It is used to treat severe bacterial infections including urinary tract infections, respiratory tract infections, skin and soft tissue infections, bone and joint infections, intra-abdominal infections, and septicemia.
Q: How does Ciprobid Injection work?
A: Ciprofloxacin inhibits bacterial DNA gyrase and topoisomerase IV enzymes, blocking bacterial DNA replication and killing the infection-causing bacteria.
Q: How is Ciprobid Injection given?
A: It is administered as a slow intravenous infusion over 60 minutes by a qualified healthcare professional in a hospital or clinical setting.
Q: What is the recommended dose?
A: The usual adult dose is 200–400 mg every 8–12 hours, depending on the type and severity of infection, as determined by the treating physician.
Q: How long is the treatment course?
A: Treatment typically lasts 7 to 14 days. The doctor may switch to oral Ciprofloxacin once the patient's condition stabilizes.
Q: What are the common side effects of Ciprobid Injection?
A: Common side effects include nausea, vomiting, diarrhea, headache, dizziness, and injection site reactions such as redness, pain, or swelling.
Q: Can Ciprobid Injection be used in children?
A: It is generally not recommended for patients under 18 years of age, as it may affect cartilage and joint development, unless the benefit clearly outweighs the risk.
Q: Is Ciprobid Injection safe during pregnancy or breastfeeding?
A: It is not recommended during pregnancy or breastfeeding. Consult your doctor for a suitable alternative.
Q: Can patients with kidney disease receive Ciprobid Injection?
A: Yes, but with dose adjustment and close monitoring, as impaired kidney function can lead to drug accumulation and increased risk of toxicity.
Q: What precautions should be followed during treatment?
A: Stay well hydrated, avoid prolonged sun exposure, inform your doctor about all current medications, and immediately report any tendon pain, allergic reactions, or neurological symptoms such as seizures or confusion.
Q: Can Ciprobid Injection cause tendon damage?
A: Yes, Ciprofloxacin has been associated with tendinitis and tendon rupture, particularly in older patients and those on corticosteroids. Discontinue use and consult your doctor if tendon pain occurs.
Interactions
| Interaction Type | Details |
|---|---|
| Antacids and minerals | May reduce Ciprofloxacin effectiveness |
| Blood thinners | May increase risk of bleeding |
| Anti-diabetic drugs | May affect blood sugar levels |
| NSAIDs | Can increase risk of nervous system side effects |
| Other antibiotics | Combined use may alter treatment effect |
Medicine Interactions
- Inform your doctor about all medicines you are currently taking
- Avoid taking antacids, calcium, iron or zinc supplements close to the dose
- Use caution when combined with blood-thinning medicines like warfarin
Food and Supplement Interactions
- Dairy products may reduce absorption if taken at the same time
- Mineral supplements can interfere with antibiotic action
- Maintain proper time gap between Ciprobid Injection and supplements
Disease Related Interactions
- Use carefully in patients with kidney disease
- Caution in epilepsy or seizure disorders
- Monitor closely in diabetes patients due to blood sugar changes
Other Important Interactions
- Avoid alcohol if advised by your doctor
- Do not combine with similar fluoroquinolone antibiotics unless prescribed
- Report any unusual side effects immediately during combined therapy
| Manufacturer | : | A. Menarini India Pvt Ltdine HCL) |
| Trade Name | : | Cipro |
| Generic Search | : | Ciprofloxacin |
| Strength | : | 10mg |
Latest Products
